Alexia Chatzipetrou
National and Kapodistrian University of Athens(GR)University General Hospital Attikon(GR)
Publications by Year
Research Areas
Asthma and respiratory diseases, Allergic Rhinitis and Sensitization, Mast cells and histamine, Inhalation and Respiratory Drug Delivery, Urticaria and Related Conditions
Most-Cited Works
- → EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders(2015)107 cited
- → Considerations on biologicals for patients with allergic disease in times of the COVID‐19 pandemic: An EAACI statement(2020)98 cited
- → Biologicals in atopic disease in pregnancy: An EAACI position paper(2020)63 cited
- → Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic(2020)37 cited
- → Anwendung von Biologika bei allergischen und Typ-2-entzündlichen Erkrankungen in der aktuellen Covid-19-Pandemiea, b, c(2020)7 cited
- → T2‐low severe asthma clinical spectrum and impact: The Greek PHOLLOW cross‐sectional study(2025)6 cited
- → PD34 ‐ Childhood mastocytosis: serum baseline total tryptase levels and extent of cutaneous disease as predictors of mast cell mediator release symptoms(2014)3 cited
- → COVID-19-vaccination in patients receiving allergen immunotherapy (AIT) or biologics - EAACI recommendations(2021)1 cited
- Bactericidal/permeability-increasing protein antineutrophil cytoplasmic antibodies (ANCA) and associated diseases: clinical relevance of an emerging ANCA target antigen.(2006)
- → Fragility fractures as the initial manifestation of indolent systemic mastocytosis(2015)